淮海医药
淮海醫藥
회해의약
JOURNAL OF HUAIHAI MEDICINE
2014年
2期
126-127
,共2页
石秀芳%黄辉%雷婷%刘雪荣%潘军峰
石秀芳%黃輝%雷婷%劉雪榮%潘軍峰
석수방%황휘%뢰정%류설영%반군봉
乙型肝炎,慢性%HBV-DNA%a-L-岩藻糖苷酶%甲胎蛋白
乙型肝炎,慢性%HBV-DNA%a-L-巖藻糖苷酶%甲胎蛋白
을형간염,만성%HBV-DNA%a-L-암조당감매%갑태단백
Hepatitis B,chronic%HBV-DNA%AFU%AFP
目的:探讨慢性乙型肝炎患者血清病毒含量与甲胎蛋白( AFP)和a-L-岩藻糖苷酶( AFU)组合检测临床应用的必要性。方法选择116例慢性乙型肝炎患者血清进行病毒含量( HBV-DNA)、AFU与AFP浓度检测,根据病毒含量分组:HBV-DNA 1×103 copies/ml以下为阴性组;HBV-DNA 1×104~1×105 copies/ml为低病毒量组;HBV-DNA 1×106~1×108 copies/ml为高病毒量组,对每组组合检测结果进行分析。结果不同病毒含量组AFU、AFP浓度变化与正常对照组比较的差异则有统计学意义(P<0.05)。 AFU与AFP的阳性比例随病毒复制量的增加而升高。结论慢性乙型肝炎患者,在定期进行病毒含量检测评估病毒的复制状况的同时,进行AFU和AFP水平组合检测发现肝组织的损害程度及演变过程,是必要的。
目的:探討慢性乙型肝炎患者血清病毒含量與甲胎蛋白( AFP)和a-L-巖藻糖苷酶( AFU)組閤檢測臨床應用的必要性。方法選擇116例慢性乙型肝炎患者血清進行病毒含量( HBV-DNA)、AFU與AFP濃度檢測,根據病毒含量分組:HBV-DNA 1×103 copies/ml以下為陰性組;HBV-DNA 1×104~1×105 copies/ml為低病毒量組;HBV-DNA 1×106~1×108 copies/ml為高病毒量組,對每組組閤檢測結果進行分析。結果不同病毒含量組AFU、AFP濃度變化與正常對照組比較的差異則有統計學意義(P<0.05)。 AFU與AFP的暘性比例隨病毒複製量的增加而升高。結論慢性乙型肝炎患者,在定期進行病毒含量檢測評估病毒的複製狀況的同時,進行AFU和AFP水平組閤檢測髮現肝組織的損害程度及縯變過程,是必要的。
목적:탐토만성을형간염환자혈청병독함량여갑태단백( AFP)화a-L-암조당감매( AFU)조합검측림상응용적필요성。방법선택116례만성을형간염환자혈청진행병독함량( HBV-DNA)、AFU여AFP농도검측,근거병독함량분조:HBV-DNA 1×103 copies/ml이하위음성조;HBV-DNA 1×104~1×105 copies/ml위저병독량조;HBV-DNA 1×106~1×108 copies/ml위고병독량조,대매조조합검측결과진행분석。결과불동병독함량조AFU、AFP농도변화여정상대조조비교적차이칙유통계학의의(P<0.05)。 AFU여AFP적양성비례수병독복제량적증가이승고。결론만성을형간염환자,재정기진행병독함량검측평고병독적복제상황적동시,진행AFU화AFP수평조합검측발현간조직적손해정도급연변과정,시필요적。
Objective To investigate the relation between HBV-DNA quantification and concentration variation of α-L-fu-cosidase(AFU)and alpha fetal protein (AFP).Methods The levels of AFU,AFP and HBV-DNA in the serum of 116 chron-ic hepatitis B patients were determined .The 116 chronic hepatitis B patients were divided into 3 groups based on the levels of HBV-DNA-a negative group (HBV-DNA<1 ×103 copies/ml), a low viral load group (HBV-DNA 1 ×104 ~1 ×105 cop-ies/ml) and a high viral load group (HBV-DNA 1 ×106 ~1 ×108 copies/ml).Results The levels of AFU and AFP in the low and high viral load groups were significantly different as compared with those of the normal control group (P<0.05).The positive rates of AFU and AFP increased along with the increase of virus replication .Conclusion HBV-DNA in the HBV car-riers should be determined at regular intervals ,the replication of HBV-DNA be assessed and the levels of AFU and AFP be simultaneously detected to diagnose the early liver lesions for early treatment .